Concepedia

Irinel Parepa

IP

Statistics

Publications

6

Citations

678

H-Index

6

Active since

2018

Affiliations

Université Paris Cité(Current)

Hôpital Bichat-Claude-Bernard

Inserm

Assistance Publique – Hôpitaux de Paris

Regeneron (United States)

Irinel Parepa is an author at Université Paris Cité specializing in cardiovascular disease, medicine, and lipid-lowering therapy.

Publications per year

2018–2022

6

Publications

6

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

, , +17

Gut Microbiota Patterns in Obese and Type 2 Diabetes (T2D) Patients from Romanian Black Sea Coast Region

Andra‐Iulia Suceveanu, Anca Pantea Stoian, Irinel Parepa et al. · Revista de Chimie · 2018 · 34 citations · Full text

, , +17

1–5 of 6